Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
Wegovy is also approved to reduce the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with obesity or overweight and known heart disease
A: Lyophilised GHK-CU 50mg powder should be stored at -20C in a sealed container, protected from light and moisture
Lyophilised vials can tolerate short transit at ambient temperature but should not be left unrefrigerated for extended periods once delivered
In clinical research, Ipamorelin has shown it can stimulate GH without disrupting other important hormone functions, making it a versatile option for workouts, performance, and healthy aging
US$ 24.30
US$ 29.17
US$ 27.80
US$ 24.20
US$ 29.22
US$ 28.96
US$ 29.26
US$ 22.79
